Recall record at a glance
| Official record | F-1922-2015 |
|---|---|
| Category | Food Recalls |
| Classification | Class III |
| FDA record status | Terminated |
| Recalling firm | Nutri-Dyn Midwest, Inc. |
| Report date | Apr 15, 2015 |
| Recall initiation date | Nov 17, 2014 |
| Quantity | 1,627 bottles |
| Location | Maple Plain, MN, United States |
Official product description
Nutri-Dyn, 5-HTP Extra Strength, Pharmaceutical Grade from Switzerland, Dietary Supplement 60 capsules in plastic bottle, 5-Hydroxytryptophan (5-HTP) 200 mg., Other Ingredients: Rice flour, magnesium stearate, and silica, UPC # 6 96859 02947 9, Sku # R200E.
Why the product was recalled
Nutri-Dyn has initiated a recall due to mislabeling. During production of CoQ-10, Lot #140186, one or more bottles were mistakenly labeled as 5-HTP Extra Strength.
Distribution information
US: AZ, CO, IA, IN, MI, MN, MT, MD, NJ, NY, SD, TX, WI. OUS: ISRAEL
How to read the classification
FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Letter.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.